PAIOF News Alert Paion Ag Aachen (PAIOF) 2.2700 02/15/2015 0

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Paion Ag Aachen (PAIOF) 2.2700 $PAIOF

PAION Founds USA Based Subsidiary and Engages an Experienced U.S. Industry Expert as CEO
Marketwired - Mon Oct 27, 7:04AM CDT
PAION AG, a Specialty Pharma Company (ISIN DE000A0B65S3) (XETRA: PA8) will increase its presence in the North American market with the formation of the US-subsidiary PAION Inc. The new company has been established recently and will now start the operational activities under the leadership of Greg Papaz, who will be reporting to Wolfgang Söhngen, CEO of PAION AG and Chairman of the new entity. The office will be located in New Jersey.

Two Scientific Remimazolam Presentations Are Accepted for ASA and ACG Meeting in October 2014
Marketwire - Wed Oct 01, 7:02AM CDT
PAION AG, a Specialty Pharma Company (ISIN DE000A0B65S3) (FRANKFURT: PA8) announces today that scientific abstracts about clinical data of Remimazolam were accepted for presentation at two major US congresses. The lead investigators will present the clinical results and PAION the hypothetical product profile of its innovative, short acting anaesthetic/sedative to professionals; consisting of gastroenterologists, anaesthetists, surgeons and intensive care professionals. The booth in the commercial exhibition is part of the planned pre-marketing activities.

Sedation Therapeutics Pipeline Review 2014 - 5 Companies & 7 Drug Profiles
M2 - Tue Sep 23, 9:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/37hrjp/sedation) has announced the addition of the "Sedation - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Sedation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Sedation and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - AstraZeneca PLC - Paion AG - Maruishi Pharmaceutical Co., Ltd. - NanoMedex Pharmaceuticals, Inc. - Advicenne Pharma Drug Profiles - propofol - ADV-6209 - remimazolam - MR-04A3 - ABP-700 - propofol Microemulsion - clonidine hydrochloride For more information visit http://www.researchandmarkets.com/research/37hrjp/sedation
AZN: 69.96 (+0.20)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading

Top 5 Most Recently Viewed Articles

TOUAX SCA Transitions to Euronext Growth Paris for Growth

Updated Category News Views 154

TOUAX SCA Announces Transfer to Euronext Growth Paris TOUAX SCA has successfully conducted its Combined General Meeting, where shareholders approved a significant decision for the company's future. The approval was for the transfer of TOUAX's listing from the regulated Euronext Paris to the Euronext Growth Paris market. Rationale Behind the Transfer This strategic move is...

Continue Reading
Knowtex's AI Boosts Veterans Affairs Medical Documentation

Updated Category News Views 11

AI's Role in Transforming VA Healthcare Documentation On an overcast Tuesday, Knowtex rolled out a fresh white paper detailing their deployment of clinical AI in the Department of Veterans Affairs. Yeah, another piece of tech jargon, but this one's stirring up some real results where it counts. "Ambient AI, Built for the Nation's Largest Health System" dives into the nuts...

Continue Reading
Key Financial Indicators Influencing Markets This Friday

Updated Category News Views 100

Important Economic Indicators Ahead As traders prepare for a busy financial day, several key economic reports and speeches are set to impact market conditions. Notable among these are the Baker Hughes rig count, a significant address by FOMC member Patrick Harker, and the latest updates from the CFTC on speculative positions. These events are crucial for investors looking...

Continue Reading
Super Micro Computer Faces Price Target Adjustment Ahead

Updated Category News Views 176

Super Micro Computer Inc Price Target Adjustment Super Micro Computer Inc (SMCI) recently had its price target revised by Mizuho, now set at $47, from the previous $40. This adjustment, however, comes while Mizuho maintains a Neutral rating on the stock, indicating careful optimism rather than enthusiasm. Overview of Recent Developments Investors received an update on the...

Continue Reading
Tensions Rise as Wildfires Devastate California’s Communities

Updated Category News Views 253

California Wildfire Crisis: A Political Firestorm California is facing unprecedented wildfires that have engulfed vast areas, leading to immense destruction and loss of life. Amidst this calamity, a clash has erupted between Gov. Gavin Newsom and President-elect Donald Trump. This confrontation has brought their differing approaches to crisis management to the forefront,...

Continue Reading